ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Passes Above 50-Day Moving Average – Time to Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $13.84 and traded as high as $17.66. ChronoScale Corporation Common Stock shares last traded at $17.41, with a volume of 402,143 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research note on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $6.00.

ChronoScale Corporation Common Stock Trading Up 5.5%

The company has a debt-to-equity ratio of 0.25, a current ratio of 1.55 and a quick ratio of 1.03. The business has a 50-day moving average of $13.99 and a 200-day moving average of $10.38. The firm has a market cap of $65.36 million, a price-to-earnings ratio of -3.41 and a beta of 1.02.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Tuesday, April 28th. The company reported ($2.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($2.01). The company had revenue of $2.14 million during the quarter, compared to analyst estimates of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

Institutional Trading of ChronoScale Corporation Common Stock

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Consolidated Portfolio Review Corp acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $333,000. Citadel Advisors LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $198,000. Geode Capital Management LLC increased its position in shares of ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after acquiring an additional 10,281 shares during the last quarter. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $67,000. Finally, Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $57,000. Institutional investors and hedge funds own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.